Our results revealed increases of INHA mRNA in most of the tumour-adjacent and HCC samples studied amounting to 9- and 225-fold increases, respectively, over disease-free liver (Figure 1, Table 2). This evidence concerns the gene INHA and hepatocellular carcinoma.